The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia

• Vijay P. S. Rawat,
• Maria Götze,
• Avinash Rasalkar,
• Naidu M. Vegi,
• Susann Ihme,
• Silvia Thoene,
• Alessandro Pastore,
• Deepak Bararia,
• Hartmut Döhner,
• Konstanze Döhner,
• Michaela Feuring-Buske,
• Leticia Quintanilla-Fend,
• Christian Buske

Affiliations

Vijay P. S. Rawat

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm

Maria Götze

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm

Avinash Rasalkar

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm

Naidu M. Vegi

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm

Susann Ihme

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm

Silvia Thoene

Institute of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, School of Medicine, Munich

Alessandro Pastore

Department of Medicine III, LMU University Hospital, Munich

Deepak Bararia

Department of Medicine III, LMU University Hospital, Munich

Hartmut Döhner

Department of Internal Medicine III, University Hospital Ulm, Ulm

Konstanze Döhner

Department of Internal Medicine III, University Hospital Ulm, Ulm

Michaela Feuring-Buske

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm;Department of Internal Medicine III, University Hospital Ulm, Ulm

Leticia Quintanilla-Fend

Institute for Pathology, Eberhard-Karls University of Tübingen, Tübingen Germany

Christian Buske

Institute of Experimental Cancer Research, Comprehensive Cancer Center, University Hospital Ulm, Ulm